Ribbon Acquisition CORP 8-K filings

Ribbon Acquisition Corp. has deposited $125,000 to extend its business combination deadline by one month to August 15, 2026.

Ribbon Acquisition Corp. has extended its business combination deadline to July 15, 2026, and regained compliance with Nasdaq listing rules.

Ribbon Acquisition Corp. received a delisting notice from Nasdaq due to $75,000 in unpaid listing fees.

Ribbon Acquisition Corp. has deposited $125,000 to extend its deadline for consummating an initial business combination by one month.

Ribbon Acquisition Corp. has adjourned its Extraordinary General Meeting to September 14, 2026, to allow more time for proxy solicitation.

Ribbon Acquisition Corp. deposited $125,000 into its trust account to secure a one-month extension for its initial business combination.

Ribbon Acquisition Corp. has further adjourned its Extraordinary General Meeting of Shareholders to April 13, 2026, to allow more time for proxy solicitation.

Ribbon Acquisition Corp. announced the adjournment of its Extraordinary General Meeting to allow more time for proxy solicitation.

Ribbon Acquisition Corp. announced the adjournment of its Extraordinary General Meeting to March 16, 2026, to allow more time for proxy solicitation.

Ribbon Acquisition Corp. has adjourned its Extraordinary General Meeting of Shareholders to allow more time for proxy solicitation.

Ribbon Acquisition Corp. shareholders approved an extension of the deadline to complete an initial business combination from January 16, 2026, to January 16, 2027.

Ribbon Acquisition Corp. shareholders approved a one-year extension for the company to complete its initial business combination, moving the deadline to January 16, 2027.

Ribbon Acquisition Corp. stockholders approved an extension for its business combination deadline to January 2027, alongside significant share redemptions.

Ribbon Acquisition Corp. stockholders approved an extension to complete its initial business combination until January 16, 2027, with a new monthly payment structure.

Ribbon Acquisition Corporation has entered into a definitive business combination agreement with Japanese healthcare and biotechnology firm DRC Medicine Ltd., valuing DRC Medicine at $350 million and aiming for a NASDAQ listing.

Ribbon Acquisition Corp announces that holders of its units may elect to separately trade the ordinary shares and rights included in the units, with trading having commenced on March 7, 2025.

Ribbon Acquisition Corp. successfully closed its initial public offering (IPO) and a private placement, raising a total of $52.2 million to pursue a business combination.

Ribbon Acquisition Corp, a blank check company, successfully priced its initial public offering of 5,000,000 units at $10.00 per unit, and subsequently announced the closing of the offering.